SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Liberty Health Sciences Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, Feb. 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights
litigation firm, announces the filing of a class action lawsuit
against Liberty Health Sciences Inc. (“Liberty Health†or “the
Companyâ€) (OTC: LHSIF) for violations of
§§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
10b-5 promulgated thereunder by the U.S. Securities and Exchange
Commission.
Investors who purchased the Company's shares between June 28, 2018 and December 3, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before March 8, 2019.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. Liberty Health was involved in a fraudulent scheme with Aphria Inc. in which transactions and acquisitions were completed specifically to provide undue benefits to Company insiders from both parties. Based on this fact, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Liberty Health, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
Sherin Mahdavian, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
[email protected]
SOURCE:
The Schall Law Firm